secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2022-09-29T23:59:59+00:00
Accession:  0001326190-22-000007
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune shareholders elect all 8 director nominees, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- All director nominees elected: votes ranged from 19.7M to 23.9M for; broker non-votes 12.6M on each.
- Ernst & Young ratified as auditor for 2022: 36.4M for, 103K against, 89K abstain.
- Say-on-pay advisory vote passed with 17.5M for, 6.5M against, 68K abstain, 12.6M broker non-votes.
- Adjournment authorized: 26.1M for, 10.3M against, 179K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619022000007/0001326190-22-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619022000007/alt-20220929x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-22-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer